Ways light scattering technologies help you if you’re in gene therapy

May 12, 2022

You require stable and pure AAV vectors to ensure your gene therapy product is safe and effective.

To develop effective vectors, you need to assess a number of their Critical Quality Attributes (CQAs). Technologies like static light scattering (SLS) and dynamic light scattering (DLS) give you lots of insight into your viral vector CQAs, including their size, purity, tendency to aggregate, and even how much genetic material they contain.

Check out this infographic to learn what SLS and DLS tell you about your vector samples, and how this info helps you develop better gene therapy products.

Previous Video
Serotyping: why, when, and how to assess your AAV therapeutic to get it approved
Serotyping: why, when, and how to assess your AAV therapeutic to get it approved

When you develop an AAV therapeutic, you need to assess many key parameters, or Critical Quality Attributes...

Up next
Learn the pros and cons of these 3 methods to serotype your AAV gene therapy vectors
Learn the pros and cons of these 3 methods to serotype your AAV gene therapy vectors

Ready to tackle your challenging stability characterizations?

Discover tools